Back

Antithrombotic therapy improves long-term prognosis in patients with atrial fibrillation and heart failure -A report from the CHART-2 Study-

29 May 2018 (08:00 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Atrial Fibrillation - Epidemiology, Prognosis, Outcome Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Takashi Shiroto

Tohoku University Hospital, Sendai (Japan)

2 More presentations in this session

Presentation thumbnail
Doctor L. Urban (Bratislava, SK)
Abstract Slides
Presentation thumbnail
Doctor S. Sasidharan (Thiruvananthapuram, IN)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Atrial Fibrillation - Epidemiology, Prognosis, Outcome

The Event

Event poster

Heart Failure 2018

29 May 2018 08:00 CET
You may be interested in
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
17 May 2025
thumbnail
Congress Presentation
Inappropriate use of anti-thrombotic therapy in patients with atrial fibrillation in a general cardiology outpatient clinic versus a multidisciplinary heart failure team
29 June 2021
thumbnail
Congress Presentation
Year-to-year change of antithrombotic strategy and clinical outcomes of atrial fibrillation patients with vascular disease in this decade: The Fushimi AF Registry.
28 August 2023
thumbnail
Congress Presentation
Two-year outcomes of patients with atrial fibrillation and heart failure: the ETNA-AF-Europe registry
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources